Literature DB >> 11218919

Animal models of hepadnavirus-associated hepatocellular carcinoma.

B C Tennant1.   

Abstract

Animal models of hepatitis B virus infection have been valuable for determining the mechanisms of hepadnavirus replication, for studies of pathogenesis, and for investigations of viral hepatocarcinogenesis. The woodchuck model also seems to be useful in the discovery and development of antiviral drugs to treat HBV infection and for testing new forms of immunotherapy. In particular, the woodchuck seems to be ideal for studying the effect of antiviral treatment and immunotherapy on the outcome of hepadnavirus infection and on survival. The median life expectancy of experimentally infected, chronic WHV carriers is approximately 29 months, and almost all develop HCC. New types of prophylaxis or therapy can be evaluated under controlled experimental conditions, in a relevant animal model, and within a reasonable time frame.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11218919     DOI: 10.1016/s1089-3261(05)70153-7

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  8 in total

1.  Combination therapy for hepatitis B.

Authors:  A M Di Bisceglie
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model.

Authors:  Kai-Wen Huang; Hui-Lin Wu; Hsiu-Lin Lin; Po-Chin Liang; Pei-Jer Chen; Shih-Hui Chen; Hsin-I Lee; Pei-Yi Su; Wen-Hsuan Wu; Po-Huang Lee; Lih-Hwa Hwang; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Monitoring the development of hepatocellular carcinoma in woodchucks using 31P-MRS.

Authors:  E J McKenzie; M Jackson; J Sun; V Volotovskyy; Marco L H Gruwel
Journal:  MAGMA       Date:  2005-08-29       Impact factor: 2.310

5.  Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Authors:  Timothy M Block; Mary Ann Comunale; Melissa Lowman; Laura F Steel; Patrick R Romano; Claus Fimmel; Bud C Tennant; W Thomas London; Alison A Evans; Baruch S Blumberg; Raymond A Dwek; Tajinder S Mattu; Anand S Mehta
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

6.  The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology.

Authors:  Chunxiao Xu; Toshiki Yamamoto; Tianlun Zhou; Carol E Aldrich; Katy Frank; John M Cullen; Allison R Jilbert; William S Mason
Journal:  Virology       Date:  2006-10-31       Impact factor: 3.616

7.  Serial percutaneous liver biopsies in laboratory rats.

Authors:  I R Corbin; G Y Minuk
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

8.  Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model.

Authors:  Yung-Tsung Li; Chun-Jen Liu; Tung-Hung Su; Huei-Ru Cheng; Yung-Ming Jeng; Hsiu-Lin Lin; Chih-Chiang Wang; Jia-Horng Kao; Pei-Jer Chen; Ding-Shinn Chen; Hui-Lin Wu
Journal:  Oncotarget       Date:  2016-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.